HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 197 | 204 | 96.6% | |
| HF004 | 2020 | 221 | 243 | 91.0% | |
| HF006 | 2021 | 273 | 301 | 90.7% | |
| HF006 | 2022 | 345 | 370 | 93.2% | |
| HF006 | 2023 | 408 | 417 | 97.8% |
